Omnicell (OMCL) Competitors $27.57 -1.12 (-3.90%) Closing price 04:00 PM EasternExtended Trading$27.56 0.00 (-0.02%) As of 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OMCL vs. MASI, AMN, WST, HSTM, MDRX, CRTX, IRTC, INSP, HNGE, and PRVAShould you be buying Omnicell stock or one of its competitors? The main competitors of Omnicell include Masimo (MASI), AMN Healthcare Services (AMN), West Pharmaceutical Services (WST), HealthStream (HSTM), Veradigm (MDRX), Cortexyme (CRTX), iRhythm Technologies (IRTC), Inspire Medical Systems (INSP), Hinge Health (HNGE), and Privia Health Group (PRVA). Omnicell vs. Its Competitors Masimo AMN Healthcare Services West Pharmaceutical Services HealthStream Veradigm Cortexyme iRhythm Technologies Inspire Medical Systems Hinge Health Privia Health Group Masimo (NASDAQ:MASI) and Omnicell (NASDAQ:OMCL) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations. Is MASI or OMCL more profitable? Omnicell has a net margin of 1.87% compared to Masimo's net margin of -25.06%. Masimo's return on equity of 22.56% beat Omnicell's return on equity.Company Net Margins Return on Equity Return on Assets Masimo-25.06% 22.56% 10.00% Omnicell 1.87%4.60%2.56% Does the media refer more to MASI or OMCL? In the previous week, Masimo had 3 more articles in the media than Omnicell. MarketBeat recorded 10 mentions for Masimo and 7 mentions for Omnicell. Omnicell's average media sentiment score of 0.66 beat Masimo's score of 0.01 indicating that Omnicell is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Masimo 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 6 Very Negative mention(s) Neutral Omnicell 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer MASI or OMCL? Masimo currently has a consensus target price of $191.60, suggesting a potential upside of 18.50%. Omnicell has a consensus target price of $44.83, suggesting a potential upside of 62.62%. Given Omnicell's higher probable upside, analysts plainly believe Omnicell is more favorable than Masimo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Masimo 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Omnicell 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57 Which has stronger earnings and valuation, MASI or OMCL? Omnicell has lower revenue, but higher earnings than Masimo. Masimo is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMasimo$2.13B4.12-$304.90M-$9.17-17.63Omnicell$1.14B1.14$12.53M$0.4659.93 Do institutionals & insiders believe in MASI or OMCL? 86.0% of Masimo shares are held by institutional investors. Comparatively, 97.7% of Omnicell shares are held by institutional investors. 9.7% of Masimo shares are held by insiders. Comparatively, 2.5% of Omnicell shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more volatility & risk, MASI or OMCL? Masimo has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500. SummaryMasimo beats Omnicell on 9 of the 16 factors compared between the two stocks. Get Omnicell News Delivered to You Automatically Sign up to receive the latest news and ratings for OMCL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OMCL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMCL vs. The Competition Export to ExcelMetricOmnicellMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.29B$2.00B$5.54B$9.14BDividend YieldN/AN/A5.01%4.00%P/E Ratio59.9434.8628.6919.46Price / Sales1.1411.38373.1779.78Price / Cash9.3754.0224.7227.47Price / Book1.038.508.255.58Net Income$12.53M-$62.39M$3.19B$252.81M7 Day Performance-4.67%4.03%5.59%3.24%1 Month Performance-5.74%10.35%9.57%11.87%1 Year Performance3.84%5.80%30.64%17.60% Omnicell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMCLOmnicell3.3346 of 5 stars$27.57-3.9%$44.83+62.6%+8.1%$1.29B$1.14B59.943,670News CoveragePositive NewsAnalyst UpgradeMASIMasimo4.0487 of 5 stars$162.45-3.1%$191.60+17.9%+45.6%$8.81B$2.09B-17.725,600Positive NewsAnalyst ForecastAMNAMN Healthcare Services4.3684 of 5 stars$21.23-3.1%$32.08+51.1%-57.5%$812.68M$2.98B-4.902,968WSTWest Pharmaceutical Services4.749 of 5 stars$221.49-0.3%$320.00+44.5%-29.7%$15.91B$2.90B34.7710,600HSTMHealthStream4.3438 of 5 stars$27.59-0.8%$31.50+14.2%-7.2%$842.05M$291.65M43.791,093Positive NewsMDRXVeradigm2.8907 of 5 stars$4.95+2.1%$13.00+162.6%-48.7%$535.91M$1.53B0.008,000CRTXCortexymeN/A$1.61+0.6%N/A+133.9%$48.54MN/A-0.5455IRTCiRhythm Technologies1.0486 of 5 stars$139.22-2.3%$138.60-0.4%+41.3%$4.44B$591.84M-44.342,000INSPInspire Medical Systems4.8813 of 5 stars$127.11-1.1%$211.91+66.7%-6.1%$3.75B$802.80M58.581,246Positive NewsAnalyst UpgradeHNGEHinge HealthN/A$43.09-7.6%$46.00+6.8%N/A$3.36BN/A0.001,514Analyst ForecastPRVAPrivia Health Group4.4874 of 5 stars$21.35-3.4%$27.77+30.1%+14.2%$2.60B$1.80B177.931,140 Related Companies and Tools Related Companies Masimo Competitors AMN Healthcare Services Competitors West Pharmaceutical Services Competitors HealthStream Competitors Veradigm Competitors Cortexyme Competitors iRhythm Technologies Competitors Inspire Medical Systems Competitors Hinge Health Competitors Privia Health Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OMCL) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omnicell, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omnicell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OMCL Stock Alerts